Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income | $90.9M | $92.2M | $147M | $168M | $83.7M | $176M | $166M | $145M | $195M | $181M |
| EPS (diluted) | $2.17 | $1.96 | $2.79 | $2.88 | $1.48 | $3.12 | $2.95 | $2.56 | $3.27 | $2.07 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $164M | $207M | $82.1M | $164M | $82.2M | $143M | $574M | $149M | $106M | $271M |
| Capital expenditures | $13.6M | $13.0M | $22.4M | $35.0M | $28.3M | $20.5M | $14.8M | $21.6M | $13.6M | $33.7M |
| Free cash flow | $150M | $194M | $59.8M | $129M | $54.0M | $122M | $559M | $127M | $92.8M | $238M |
| Share buybacks | $0.00 | $0.00 | $7.06M | $62.9M | $24.6M | $21.3M | $0.00 | $0.00 | $0.00 | $13.3M |
| Dividends paid | $29.7M | $34.4M | $43.6M | $50.9M | $50.1M | $50.0M | $50.0M | $50.3M | $53.7M | $78.6M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $306M | $281M | $569M | $415M | $633M | $1.88B | $576M | $801M | $1.09B | $1.07B |
| Total assets | $8.70B | $9.83B | $12.9B | $13.4B | $14.9B | $16.8B | $17.0B | $17.4B | $18.0B | $26.8B |
| Total liabilities | $7.47B | $8.31B | $10.9B | $11.3B | $12.8B | $14.6B | $14.9B | $15.1B | $15.4B | $22.9B |
| Long-term debt | $202M | $208M | $264M | $377M | $475M | $471M | $428M | $429M | $431M | $500M |
| Shareholders' equity | $1.23B | $1.51B | $2.04B | $2.13B | $2.13B | $2.21B | $2.14B | $2.30B | $2.68B | $3.88B |
| Retained earnings | $338M | $397M | $501M | $617M | $616M | $742M | $858M | $952M | $1.09B | $1.20B |
| Shares (wtd avg diluted) | 42.0M | 47.0M | 52.6M | 58.2M | 56.5M | 56.4M | 56.2M | 56.4M | 59.7M | 87.5M |
Every figure is extracted from RENASANT CORP’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.